Literature DB >> 10411981

Centrally administered galanin blocks morphine place preference in the mouse.

V Zachariou1, K Parikh, M R Picciotto.   

Abstract

Galanin is a neuropeptide with appetitive, antinociceptive and neuroendocrine functions. Galanin and galanin binding sites are present in brain areas that mediate reinforcement, such as nucleus accumbens and ventral tegmental area, as well as locus coeruleus, an area known to be involved in development of drug dependence and withdrawal. This localization, coupled with the observation that there is a strong interaction between morphine and galanin in spinal cord, made it of interest to study whether galanin might have effects on morphine reinforcement. Using the place preference paradigm we found that galanin (1 microg i.c.v.) alone does not possess reinforcing or aversive properties but attenuates the preference conditioned by peripheral administration of morphine (5 mg/kg s.c.). Quantitative receptor autoradiography showed that morphine treatment that could condition a place preference decreased galanin binding in the nucleus accumbens and increased galanin binding in the locus coeruleus. In contrast, acute naltrexone administration increased galanin binding in the nucleus accumbens, suggesting that levels of galanin binding are tonically regulated by opioid receptors in that area. Contrary to what is seen in the spinal cord, these results indicate that galanin and morphine have an antagonistic interaction in the brain that results in attenuation of morphine reinforcement by activation of the galaninergic system. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411981     DOI: 10.1016/s0006-8993(99)01476-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  20 in total

1.  Locomotion and self-administration induced by cocaine in 129/OlaHsd mice lacking galanin.

Authors:  Christian Brabant; Anna S Kuschpel; Marina R Picciotto
Journal:  Behav Neurosci       Date:  2010-12       Impact factor: 1.912

Review 2.  Galanin: a potential role in mesolimbic dopamine-mediated instrumental behavior.

Authors:  John K Robinson; Ariel Brewer
Journal:  Neurosci Biobehav Rev       Date:  2008-06-03       Impact factor: 8.989

3.  Opioid-galanin receptor heteromers differentiate the dopaminergic effects of morphine and methadone.

Authors:  Randal A Serafini; Venetia Zachariou
Journal:  J Clin Invest       Date:  2019-05-28       Impact factor: 14.808

4.  Pharmacogenetic association of the galanin receptor (GALR1) SNP rs2717162 with smoking cessation.

Authors:  Allison B Gold; E Paul Wileyto; Adriana Lori; David Conti; Joseph F Cubells; Caryn Lerman
Journal:  Neuropsychopharmacology       Date:  2012-02-29       Impact factor: 7.853

5.  Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area.

Authors:  Estefanía Moreno; César Quiroz; William Rea; Ning-Sheng Cai; Josefa Mallol; Antoni Cortés; Carme Lluís; Enric I Canela; Vicent Casadó; Sergi Ferré
Journal:  J Neurosci       Date:  2016-12-22       Impact factor: 6.167

6.  Galanin-induced decreases in nucleus accumbens/striatum excitatory postsynaptic potentials and morphine conditioned place preference require both galanin receptor 1 and galanin receptor 2.

Authors:  Emily B Einstein; Yukiko Asaka; Mark F Yeckel; Michael J Higley; Marina R Picciotto
Journal:  Eur J Neurosci       Date:  2013-02-07       Impact factor: 3.386

7.  Galanin protects against behavioral and neurochemical correlates of opiate reward.

Authors:  Jessica J Hawes; Darlene H Brunzell; Roopashree Narasimhaiah; Ulo Langel; David Wynick; Marina R Picciotto
Journal:  Neuropsychopharmacology       Date:  2007-10-24       Impact factor: 7.853

8.  The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal.

Authors:  Venetia Zachariou; Darlene H Brunzell; Jessica Hawes; Diann R Stedman; Tamas Bartfai; Robert A Steiner; David Wynick; Ulo Langel; Marina R Picciotto
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

Review 9.  Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors.

Authors:  Marina R Picciotto; Christian Brabant; Emily B Einstein; Helen M Kamens; Nichole M Neugebauer
Journal:  Brain Res       Date:  2009-08-20       Impact factor: 3.252

10.  Hypothalamic injection of non-opioid peptides increases gene expression of the opioid enkephalin in hypothalamic and mesolimbic nuclei: Possible mechanism underlying their behavioral effects.

Authors:  Olga Karatayev; Jessica R Barson; Guo-Qing Chang; Sarah F Leibowitz
Journal:  Peptides       Date:  2009-09-24       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.